Global Tumor Biomarker Test Kits Market Research Report – Segmented By Tumor Detection (Lung, Breast, Ovarian, Liver, Stomach, Prostate, Others); By Type (Protein, Genetic, Others); By Application (Diagnostic, Research Institutes, Pharmaceutical Companies); By Technology (Immunoassay, Imaging, Omics, Others); and Region - Size, Share, Growth Analysis | Forecast (2024 – 2030)
Published: 2024 - January
Report Code: IM-15558
Format:
Region: Global
Chapter 1. Tumor Biomarker Test Kits Market – Scope & Methodology
1.1 Market Segmentation
1.2 Assumptions
1.3 Research Methodology
1.4 Primary Sources
1.5 Secondary Sources
Chapter 2. Tumor Biomarker Test Kits Market – Executive Summary
2.1 Market Size & Forecast – (2023 – 2030) ($M/$Bn)
2.2 Key Trends & Insights
2.3 COVID-19 Impact Analysis
2.3.1 Impact during 2023 – 2030
2.3.2 Impact on Supply – Demand
Chapter 3. Tumor Biomarker Test Kits Market – Competition Scenario
3.1 Market Share Analysis
3.2 Product Benchmarking
3.3 Competitive Strategy & Development Scenario
3.4 Competitive Pricing Analysis
3.5 Supplier - Distributor Analysis
Chapter 4. Tumor Biomarker Test Kits Market - Entry Scenario
4.1 Case Studies – Start-up/Thriving Companies
4.2 Regulatory Scenario - By Region
4.3 Customer Analysis
4.4 Porter's Five Force Model
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Powers of Customers
4.4.3 Threat of New Entrants
4.4.4 .Rivalry among Existing Players
4.4.5 Threat of Substitutes
Chapter 5. Tumor Biomarker Test Kits Market - Landscape
5.1 Value Chain Analysis – Key Stakeholders Impact Analysis
5.2 Market Drivers
5.3 Market Restraints/Challenges
5.4 Market Opportunities
Chapter 6. Tumor Biomarker Test Kits Market - By Tumor Detection
6.1 Lung
6.2 Breast
6.3 Ovarian
6.4 Liver
6.5 Stomach
6.6 Prostate
6.7 Others
Chapter 7. Tumor Biomarker Test Kits Market - By Type
7.1 Protein
7.2 Genetic
7.3 Others
Chapter 8. Tumor Biomarker Test Kits Market - By Application
8.1 Diagnostic Laboratories
8.2 Research Institutes
8.3 Pharmaceutical Companies
Chapter 9. Tumor Biomarker Test Kits Market - By Technology
9.1 Immunoassay
9.2 Imaging
9.3 Omics
9.4 Others
Chapter 10. Tumor Biomarker Test Kits Market – By Region
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Latin America
10.5 The Middle East
10.6 Africa
Chapter 11. Tumor Biomarker Test Kits Market – Key Players
11.1 Prestige Biopharma
11.2 Bio Agilytix Labs
11.3 Euro fins Scientific
11.4 SGS SA
11.5 OncoDEEP
11.6 ICON Plc
11.7 IQVIA
11.8 Syneos Health
11.9 Nonagen Bioscience
11.10 Intertek Group
Download Sample
Choose License Type
2850
5250
4500
1800
Frequently Asked Questions
The global Tumor Biomarker Test Kits Market is estimated to be worth USD 13.1 Billion in 2022 and is projected to reach the value of USD 29.8 Billion in 2030 growing at the CAGR of 10.8% during the forecast period 2023 – 2030
Rise in several tumors across the world and increasing research and developmental activities coupled with investment by companies.
Based on Type, the Global Tumor Biomarker Test Kits are segmented into Protein, Genetic, and Others.
The United States is the most dominating country in the region of North America for the Global Tumor Biomarker Test Kits Market.
Prestige Biopharma, Bio Agilytix Labs, Euro fins Scientific, SGS SA, OncoDEEP, ICON Plc, IQVIA, Syneos Health, Nonagen Bioscience, Intertek Group
